In the newly created position, Stewart is slated to work closely with the BD executive team to “drive shareholder value and communicate the company’s long-term growth strategy,” according to a news release.
Stewart previously held roles at multiple Wall Street investment banks over two decades, most recently leading the medical technology research franchise at Barclays Capital. Institutional Investor has named her as one of the top three analysts in the medical supplies & devices category several times, BD said.
“I have watched through the analyst lens as BD has transformed into a global medical technology innovator,” Stewart said in the release. “I am excited by BD’s current strategic direction and believe the company has significant potential to optimize shareholder value. I am thrilled to undertake this important new role.”
Stewart is set to join BD on Aug. 31 and will report to the company’s executive VP, CFO & chief administrative officer Christopher Reidy.
“Kristen’s wealth of experience and long-standing relationships throughout the investment community will bring meaningful value to BD,” Reidy said. “I am excited about the alignment of both strategy and IR under Kristen’s leadership and look forward to welcoming her to the team.”